- Home
- CODX vs IINN Comparison
CODX vs IINN Comparison
Compare CODX & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- IINN
- Stock Information
- Founded
- CODX 2013
- IINN 2018
- Country
- CODX United States
- IINN Israel
- Employees
- CODX N/A
- IINN N/A
- Industry
- CODX Medical/Dental Instruments
- IINN Medical/Dental Instruments
- Sector
- CODX Health Care
- IINN Health Care
- Exchange
- CODX Nasdaq
- IINN Nasdaq
- Market Cap
- CODX 9.8M
- IINN 13.7M
- IPO Year
- CODX 2017
- IINN 2021
- Fundamental
- Price
- CODX $0.27
- IINN $1.40
- Analyst Decision
- CODX Buy
- IINN Strong Buy
- Analyst Count
- CODX 2
- IINN 1
- Target Price
- CODX $5.50
- IINN $2.00
- AVG Volume (30 Days)
- CODX 1.0M
- IINN 1.5M
- Earning Date
- CODX 08-07-2025
- IINN 08-14-2025
- Dividend Yield
- CODX N/A
- IINN N/A
- EPS Growth
- CODX N/A
- IINN N/A
- EPS
- CODX N/A
- IINN N/A
- Revenue
- CODX $3,497,583.00
- IINN N/A
- Revenue This Year
- CODX N/A
- IINN N/A
- Revenue Next Year
- CODX $42.11
- IINN N/A
- P/E Ratio
- CODX N/A
- IINN N/A
- Revenue Growth
- CODX N/A
- IINN N/A
- 52 Week Low
- CODX $0.23
- IINN $0.40
- 52 Week High
- CODX $2.23
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- CODX 40.44
- IINN 67.33
- Support Level
- CODX $0.24
- IINN $1.16
- Resistance Level
- CODX $0.29
- IINN $1.65
- Average True Range (ATR)
- CODX 0.02
- IINN 0.17
- MACD
- CODX -0.00
- IINN 0.04
- Stochastic Oscillator
- CODX 13.79
- IINN 71.78
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.